CP-206 Safety of direct acting antiviral and antiretrovirals drugs in HCV patients co-infected with hiv-1: Clinical practice experience

BackgroundFor novel direct acting antiviral (DAA) drugs, HIV/HCV patients have achieved similar sustained virologic response rates as HCV monoinfected patients, but experience in safety and drug interactions with antiretroviral (ARV) regimens is limited in clinical practice, especially in cirrhotic...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2016-03, Vol.23 (Suppl 1), p.A91-A91
Hauptverfasser:	Canamares-Orbis, I, Izquierdo-Garcia, E, Esteban-Alba, C, Saez, J, Such-Diaz, A, Barrueco-Fernandez, N, Escobar-Rodriguez, I
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiretroviral drugs Clinical medicine Drug interactions Laboratories Liver cirrhosis Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!